Highest-materiality recent filing
WTW shareholders approve all proposals at 2026 AGM; directors elected, say-on-pay passed
All nine director nominees elected; Paul Reilly received most against votes (2.6M against of 84.4M cast).
WTW Q1 2026: revenue $2.4B (+8% YoY), adj. diluted EPS $3.72 (+19%), organic growth 3%
Revenue $2.412B (+8% YoY); organic growth 3%; diluted EPS $3.10 (+33%).
WTW Q4 adj. EPS $8.12 (+2%), organic rev +6%; FY adj. EPS $17.08 (+5%)
Q4 revenue $2.94B (organic +6%); adj. EPS $8.12 (+2%); operating margin 34.6%.
WTW completes acquisition of Newfront; expands U.S. middle market & tech capabilities
Completed acquisition of Newfront, a top-40 U.S. broker specializing in tech, fintech, and life sciences.
WTW enters $775M delayed draw term loan to finance Newfront acquisition
Delayed draw term loan facility of $775M, unsecured, matures 3 years from initial draw or 3 years after 2 months post-acquisition.
Willis Towers Watson issues $1B in senior notes to fund Newfront acquisition & refinance debt
Issued $700M 4.550% notes due 2031 and $300M 5.150% notes due 2036; net proceeds ~$990M.
Willis North America prices $1B senior notes; proceeds tied to Newfront deal
Priced $700M 4.550% notes due 2031 and $300M 5.150% notes due 2036.
WTW to acquire Newfront for $1.3B to expand U.S. middle-market and tech capabilities
Upfront payment of $1.05B ($900M cash + $150M equity) plus up to $250M contingent consideration; total $1.3B.
WTW reports Q3 2025 adjusted EPS $3.07 (+11% YoY); organic revenue growth 5%
Revenue $2.29B flat YoY (organic +5%); diluted EPS $3.11 vs loss $16.44 prior year.
WTW Q3 adj EPS $3.07 (+11% YoY); organic revenue +5%; margins expand 230 bps
Revenue $2.29B flat YoY as TRANZACT sale offset; organic revenue grew 5%.
WTW enters $1.5B revolving credit facility, maturing 2030
$1.5B revolving credit facility maturing October 17, 2030, replacing prior 2021 credit agreement.
WTW Q2 2025: Adj. EPS $2.86 (+20% YoY), organic revenue +5%, margins expand
Revenue $2.26B flat (organic +5%); Diluted EPS $3.32 (+144%), Adjusted EPS $2.86 (+20%).
Paul Reilly succeeds Paul Thomas as non-executive Chair of Willis Towers Watson
Shareholders elected all 9 director nominees; votes ranged from 85.2M to 87.9M in favor.
WTW Q1 revenue -5% to $2.2B; organic +5%; adj. EPS flat at $3.13
GAAP diluted EPS $2.33 (+27% YoY); adjusted diluted EPS $3.13 (flat YoY).
WTW appoints Paul Reilly as Non-Executive Chair; Paul Thomas to retire at 2025 AGM
Paul Thomas retires as Non-Executive Chair at the 2025 AGM (May 2025) and will not stand for re-election.
WTW Q4 adjusted EPS $8.13 (+9%); FY adjusted EPS $16.93 (+17%); revenue up 5% organic
Q4 revenue $3.04B (+4% reported, +5% organic); FY revenue $9.93B (+5% reported and organic).
WTW completes sale of TRANZACT to GTCR and Recognize
Sale closed on Dec 31, 2024; announced Jan 2, 2025.
WTW Q3 adj. EPS $2.93 beats; revenue up 6% organic; FY24 guidance reaffirmed
Revenue $2.29B, up 6% YoY (organic 6%); segments: HWC +4%, R&B +10%.
WTW to sell TRANZACT for $632.4M; expects Q3 impairment charges of $1.6–$2.1B
Sale to GTCR and Recognize at $632.4M subject to adjustments; expected close by end of 2024.
WTW Q2 revenue $2.27B (+5%), adj. EPS $2.55 (+24%); raises 2024 outlook low end
Revenue $2.27B, reported +5%, organic +6%; diluted EPS $1.36 (+55%), adjusted diluted EPS $2.55 (+24%).
All 10 director nominees elected; highest against votes: Carl Hess (3.9M) and Paul Thomas (4.1M).
WTW Q1 revenue up 4% to $2.34B; adj. EPS $3.29 beats prior year; guidance reaffirmed
Q1 revenue $2.34B (+4% reported, +5% organic); diluted EPS $1.83 (down 3%); adjusted diluted EPS $3.29 (+16% YoY).
The Board has selected Paul Reilly, an independent director of the Board, to become the Non-Executive Chair of the Board effective as of the conclusion of the 2025 AGM, subject to his re-election.
Paul Thomas, the current Non-Executive Chair of the Board of Directors (the “Board”) of Willis Towers Watson Public Limited Company (the “Company”), informed the Board that he intends to retire at the end of his current term and will not stand for reelection at the Company’s 2025 Annual Meeting of Stockholders (“AGM”).
Max materiality 0.85 · Median 0.68 · Most common event earnings